We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
First application of focused low-energy extracorporeal shockwave therapy in a patient with severe hemophilia A and plantar fasciitis.
- Authors
Wagner, Barbara; Ay, Cihan; Mickel, Michael; Crevenna, Richard
- Abstract
Further research evaluating an increased number of patients both under monoclonal antibody therapy as well as under factor treatment should confirm its safety. The primary aim of care is to prevent and treat bleeding episodes with the deficient clotting factor or non-factor therapies such as emicizumab, a monoclonal antibody that mimics factor VIII function [[1]-[3]]. First application of focused low-energy extracorporeal shockwave therapy in a patient with severe hemophilia A and plantar fasciitis.
- Subjects
PLANTAR fasciitis; HEMOPHILIA; HEMOPHILIACS; EXTRACORPOREAL shock wave therapy; SHOCK waves; MEDICAL societies
- Publication
Wiener Klinische Wochenschrift, 2021, Vol 133, Issue 5/6, p245
- ISSN
0043-5325
- Publication type
Letter
- DOI
10.1007/s00508-020-01687-w